23 November 2017
News and Views
Links and Services
June's issue of Gut investigates the effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Helicobacter pylori infection and overexpression of cyclo-oxygenase-2 (COX-2) are associ
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors